Antigenotoxic effects of ascorbic acid against megestrol acetate-induced genotoxicity in mice

Yasir Hasan Siddique1, Tanveer Beg, Mohammad Afzal

  • 1Section of Genetics, Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India. yasir_hasansiddique@rediffmail.com

Insights

Megestrol acetate increased genotoxicity in mice, evidenced by chromosomal aberrations (CAs) and sister chromatid exchanges (SCEs). Ascorbic acid demonstrated antigenotoxic effects, significantly reducing this megestrol acetate-induced damage in a dose-dependent manner.

Area of Science:

  • Toxicology
  • Genetics
  • Pharmacology

Background:

  • Synthetic progestins like megestrol acetate can induce genotoxicity.
  • This damage is potentially mediated by the generation of free oxygen radicals.
  • Antioxidant natural products may mitigate steroid-induced genotoxic effects.

Purpose of the Study:

  • To investigate the genotoxicity of megestrol acetate in mouse bone marrow cells.
  • To evaluate the antigenotoxic potential of ascorbic acid against megestrol acetate-induced damage.
  • To determine the dose-dependent effects of ascorbic acid.

Main Methods:

  • Mice were administered varying doses of megestrol acetate intraperitoneally.
  • Sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) were analyzed in bone marrow cells.
  • Ascorbic acid was co-administered with megestrol acetate to assess protective effects.

Main Results:

  • Megestrol acetate significantly increased SCEs and CAs at doses of 16.25 and 32.50 mg/kg.
  • Co-administration of ascorbic acid dose-dependently decreased megestrol acetate-induced CAs and SCEs.
  • A significant protective effect was observed with 60 mg/kg ascorbic acid.

Conclusions:

  • Megestrol acetate exhibits genotoxic potential in mouse bone marrow.
  • Ascorbic acid acts as an antigenotoxic agent against megestrol acetate-induced genotoxicity.
  • Ascorbic acid's protective effect is dose-dependent, highlighting its therapeutic potential.